Summary
JOIN PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €569,132 and a net result of €41,311. Equity is growing by about 2.9% per year across the filed financial years. Its solvency ranks better than 48% of 6,651 sector peers (NACE 64, financial year 2025). The company has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- JOIN PHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Enkel besluit bestuursorgaan, Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Één of meer bestuurders, met of zonder beperking van duur” (deed in Dutch)“Vaste of evenredige vergoeding, algemene kosten,los van representatie-,reis- en verplaatsingskosten” (deed in Dutch)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Procedure- en expertisekosten voor helft overdrager en helft koper(s) naar evenredigheid aantal bij meerdere kopers;zelfde bij weigering…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Friday of June at 20:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vormen vereist voor statutenwijziging, elk moment” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Een of meerdere vereffenaars aanduiden,bevoegdheden omlijnen,vergoeding bepalen, bestuurder(s) in functie als vereffenaar(s) krachtens…” (deed in Dutch)